India's HPV vaccination campaign shows how digital platforms and cooperative federalism can deliver preventive healthcare at scale. Analyse.
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
Preventive healthcare works at scale only when supply, data and last-mile delivery move together. India's National HPV Vaccination Campaign began in February 2026 [2]. In under nine months it gave more than 1 crore single doses to 14-year-old girls, reaching nearly 87% of the annual cohort [1]. Its design shows both the strengths and the limits of a digital-plus-federal model.
Digital platform: U-WIN as the backbone
- Real-time monitoring and beneficiary tracking let district managers find eligible girls who are still unvaccinated [1].
- Citizen interface: parents can book slots and download certificates, which makes the process transparent [1].
- Safety governance: AEFI protocols and links to 24×7 healthcare centres build trust in vaccinating minors [1].
Cooperative federalism: shared delivery
- The Union, States/UTs and districts share delivery, and States adapt it to rural, remote and urban settings [1].
- Merger, not duplication: earlier programmes in Bihar, Tamil Nadu and Sikkim were folded into the national drive [1].
- Peer performance: six States report 100% coverage, and Uttar Pradesh leads in absolute numbers with over 29.33 lakh girls [1].
- Last-mile trust: ASHAs, ANMs and teachers counter misinformation and obtain parental consent [1].
Enablers of scale
- Single dose: WHO's SAGE backed it in 2022, and 57 countries used it by 2024. It lowers cost and simplifies logistics [3].
- CERVAVAC, India's first indigenous cervical cancer vaccine, makes supply more secure [4].
Limits of the model
- Campaign, not routine: the HPV vaccine was outside the UIP as of December 2024, so annual funding is not guaranteed [4].
- Estimated denominators: coverage is measured against RGI 2021 projections. "100%" means a target was met, not that every girl was counted, and about 13% of the cohort is still unvaccinated [1].
- Other pillars lag: by July 2025 only 10.18 crore of 25.42 crore eligible women had been screened [5]. WHO's 90-70-90 strategy needs screening and treatment as well as vaccination [6].
U-WIN supplied the data and cooperative federalism supplied the delivery network. Together they took the campaign close to full coverage of its age group. To make this last, HPV vaccination should join the UIP, a catch-up drive should reach older girls, and U-WIN should be linked to the National NCD Portal so vaccinated girls are called for screening at 30. That would move India toward WHO's 2030 elimination targets and SDG 3.4.
Sources
- 1PIB: India crosses 1 crore HPV vaccine doses (MoHFW, Nov 2026)1 crore doses, ~87% coverage, U-WIN features, AEFI safeguards, State roles, merger of State programmes, six States at 100%, UP figures, frontline workers, RGI 2021 cohort
- 2PIB: Free nationwide HPV vaccination campaign for girls aged 14 (Feb 2026)February 2026 launch of the campaign
- 3WHO: WHO adds an HPV vaccine for single-dose use (4 Oct 2024)single-dose evidence; 57 countries using it
- 4Lok Sabha Unstarred Question No. 3001 (13 Dec 2024)CERVAVAC as India's first indigenous vaccine; HPV vaccine not part of UIP
- 5PIB: 10.18 crore women screened for cervical cancer under Ayushman Arogya Mandirs and NHM (2025)screening of 10.18 crore out of 25.42 crore eligible women
- 6WHO: Global strategy to accelerate the elimination of cervical cancer as a public health problem (2020)the 90-70-90 targets for 2030